BOSHOFF CHRISTOFFEL 4

What Happened
Christoffel Boshoff, President, R&D at Pfizer (PFE), received an earn-out of performance share awards totaling 13,383 shares on 2026-02-25 (reported as an Award, code A). As part of the award settlement, 6,833 shares were withheld to satisfy tax obligations (code F) at an implied value of $27.09 per share, resulting in ~ $185,106 withheld. The award shares were reported with an acquisition price of $0.00 (standard for granted awards).

Key Details

• Transaction date: 2026-02-25; filing date: 2026-02-27 (appears timely; Form 4 typically due within two business days).
• Award: 13,383 shares acquired (code A) at $0.00.
• Withholding: 6,833 shares withheld/disposed (code F) at $27.09, totaling ~$185,106 to cover taxes.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes: F1 = earn-out of performance share awards (including dividend equivalents). F2 = withholding of shares to satisfy tax obligations on the earn-out.

Context
This was not an open-market purchase or sale for investment purposes but the settlement of performance-based equity. Withholding shares to cover taxes is a common administrative step and does not necessarily indicate the insider’s view of the stock. For derivative/award transactions like this, the key takeaway for investors is the issuance of performance-based shares and routine tax withholding rather than a directional trading signal.